TickerFacts.

Mira Pharmaceuticals, Inc. (MIRA): Shareholders' Equity

Annual figures by period end, from SEC filings.

$10.39M
As of 2025-12-31
$8.16M
As of 2026-06-30
2022-12-31: -$596.2K2023-12-31: $4.37M2024-12-31: $2.20M2025-12-31: $10.39M$10.39M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$10.39M+372.4%2026-03-31, Balance as of period end
2024-12-31$2.20M-49.7%2026-03-31, Balance as of period end
2023-12-31$4.37Mn/m2025-03-28, Balance as of period end
2022-12-31-$596.2Kn/a2024-04-01, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Mira Pharmaceuticals, Inc. (MIRA)2025-12-31$10.39M+372.4%
MetaVia Inc. (MTVA)2025-12-31$5.33M-32.8%
Decoy Therapeutics Inc. (DCOY)2025-12-31$5.89M+289.6%
Lantern Pharma Inc. (LTRN)2025-12-31$6.53M-69.2%
NewcelX Ltd. (NCEL)2025-12-31$7.25Mn/m
Curanex Pharmaceuticals Inc (CURX)2025-12-31$11.22Mn/m
Revelation Biosciences, Inc. (REVB)2025-12-31$8.86M+88.2%
Traws Pharma, Inc. (TRAW)2025-12-31-$629.0Kn/m
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)2025-12-31$2.25M+217.9%

Compare MIRA, MTVA, DCOY, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗